Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douwe J Mulder

Showing results (41-50 of 73) with videos related to

Pageof 8
Sort By:
Antioxidants (Basel, Switzerland)|October 23, 2021
Plasma Nitrate Levels Are Related to Metabolic Syndrome and Are Not Altered by Treatment with DPP-4 Inhibitor Linagliptin: A Randomised, Placebo-Controlled Trial in Patients with Early Type 2 Diabetes MellitusMelanie Reijrink, Stefanie A De Boer, Anniek M Van Roon, et al.
Clinical Pharmacology and Therapeutics|March 10, 2023
Feasibility Study to Assess Canagliflozin Distribution and Sodium-Glucose Co-Transporter 2 Occupancy Using [<sup>18</sup> F]Canagliflozin in Patients with Type 2 DiabetesSjoukje van der Hoek, Antoon T M Willemsen, Ton Visser, et al.
Frontiers in Immunology|July 6, 2023
The soluble receptor for advanced glycation end products is potentially predictive of pulmonary arterial hypertension in systemic sclerosisIsabella M Atzeni, Yehya Al-Adwi, Berber Doornbos-van der Meer, et al.
Physiological Reports|March 28, 2019
Rapid free thiol rebound is a physiological response following cold-induced vasoconstriction in healthy humans, primary Raynaud and systemic sclerosisAmaal Eman Abdulle, Anniek M van Roon, Andries J Smit, et al.
Journal of the American Heart Association|December 29, 2023
Plasma Calprotectin Levels Associate With New-Onset Hypertension in the General Population: A Prospective Cohort StudyArno R Bourgonje, Martin F Bourgonje, Sacha la Bastide-van Gemert, et al.
Atherosclerosis|October 12, 2019
Visceral adipose tissue volume is associated with premature atherosclerosis in early type 2 diabetes mellitus independent of traditional risk factorsMelanie Reijrink, Stefanie A de Boer, Daan S Spoor, et al.
Seminars in Arthritis and Rheumatism|August 9, 2022
Treatment of resistant Raynaud's phenomenon with single-port thoracoscopic sympathicotomy: One-year follow-upMichiel Kuijpers, Saskia C van de Zande, Anniek M van Roon, et al.
Frontiers in Cardiovascular Medicine|February 26, 2021
Systemic Oxidative Stress, Aging and the Risk of Cardiovascular Events in the General Female PopulationMartin F Bourgonje, Arno R Bourgonje, Amaal E Abdulle, et al.
BMJ Open|March 13, 2025
Hand function impairment in Systemic sclerosis: Outcomes, Mechanisms and Experience (HANDSOME) - a longitudinal observational multicentre study protocolMark Greveling, Voon H Ong, Christopher Denton, et al.
Kidney International Reports|May 6, 2024
A Prospective Study of the Association Between Plasma Calprotectin Levels and New-Onset CKD in the General PopulationArno R Bourgonje, Martin F Bourgonje, Sacha la Bastide-van Gemert, et al.
Pageof 8

Showing results (41-50 of 73) with videos related to

Sort By:
Pageof 8
Antioxidants (Basel, Switzerland)|October 23, 2021
Plasma Nitrate Levels Are Related to Metabolic Syndrome and Are Not Altered by Treatment with DPP-4 Inhibitor Linagliptin: A Randomised, Placebo-Controlled Trial in Patients with Early Type 2 Diabetes MellitusMelanie Reijrink, Stefanie A De Boer, Anniek M Van Roon, et al.
Clinical Pharmacology and Therapeutics|March 10, 2023
Feasibility Study to Assess Canagliflozin Distribution and Sodium-Glucose Co-Transporter 2 Occupancy Using [<sup>18</sup> F]Canagliflozin in Patients with Type 2 DiabetesSjoukje van der Hoek, Antoon T M Willemsen, Ton Visser, et al.
Frontiers in Immunology|July 6, 2023
The soluble receptor for advanced glycation end products is potentially predictive of pulmonary arterial hypertension in systemic sclerosisIsabella M Atzeni, Yehya Al-Adwi, Berber Doornbos-van der Meer, et al.
Physiological Reports|March 28, 2019
Rapid free thiol rebound is a physiological response following cold-induced vasoconstriction in healthy humans, primary Raynaud and systemic sclerosisAmaal Eman Abdulle, Anniek M van Roon, Andries J Smit, et al.
Journal of the American Heart Association|December 29, 2023
Plasma Calprotectin Levels Associate With New-Onset Hypertension in the General Population: A Prospective Cohort StudyArno R Bourgonje, Martin F Bourgonje, Sacha la Bastide-van Gemert, et al.
Atherosclerosis|October 12, 2019
Visceral adipose tissue volume is associated with premature atherosclerosis in early type 2 diabetes mellitus independent of traditional risk factorsMelanie Reijrink, Stefanie A de Boer, Daan S Spoor, et al.
Seminars in Arthritis and Rheumatism|August 9, 2022
Treatment of resistant Raynaud's phenomenon with single-port thoracoscopic sympathicotomy: One-year follow-upMichiel Kuijpers, Saskia C van de Zande, Anniek M van Roon, et al.
Frontiers in Cardiovascular Medicine|February 26, 2021
Systemic Oxidative Stress, Aging and the Risk of Cardiovascular Events in the General Female PopulationMartin F Bourgonje, Arno R Bourgonje, Amaal E Abdulle, et al.
BMJ Open|March 13, 2025
Hand function impairment in Systemic sclerosis: Outcomes, Mechanisms and Experience (HANDSOME) - a longitudinal observational multicentre study protocolMark Greveling, Voon H Ong, Christopher Denton, et al.
Kidney International Reports|May 6, 2024
A Prospective Study of the Association Between Plasma Calprotectin Levels and New-Onset CKD in the General PopulationArno R Bourgonje, Martin F Bourgonje, Sacha la Bastide-van Gemert, et al.
Pageof 8